PILOT for The Precision Exercise Regimen for Cancer Care (PERCC) Study
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Utah
About this trial
This study is designed to evaluate whether a precision exercise regimen is feasible to implement within cancer populations, specifically stage II-III primary lung cancer patients receiving multimodal therapy, and delivered through telehealth.
Eligibility criteria
Qualifiers
Ages 18 and older at time of diagnosis
Patient diagnosed with stage II and III non-small cell lung cancer (NSCLC)
Patient receives either neoadjuvant chemotherapy or immunotherapy and surgery
Patient able to follow direction and complete questionnaires in English or Spanish
Disqualifiers
Morbidly obese (BMI >40 kg/m2 ) or anorexic (BMI <17.5 kg/m2 )
Abnormalities on screening physical exam per study physicians or physical therapist to contraindicate participation in exercise program compliance
Alcohol or drug abuse, significant mental or emotional problems that would interfere with compliance (assessed by NCCN Distress Thermometer)
Patient scheduled to receive single modality cancer treatment (unimodal therapy), scheduled to begin treatment within 2 weeks of the pre-treatment clinic visit, or for whom treatment has already started
Trial design
Treatments tested in this trial
- Precision Exercise Regimen for Cancer Care (PERCC)
Treatment groups
20 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov